Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1060 Optimally engineered IL18 Fc-fusion proteins balance potency and pharmacokinetics to promote strong anti-tumor activity
Compose a Response to This Article
Other responses
No responses have been published for this article.
